Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 06, 2022 10:15 ET | Source: Straits Research

Hemodialysis Market Size is projected to reach USD 136.84 Billion by 2031, growing at a CAGR of 4.8%: Straits Research

New York, United States, Dec. 06, 2022 (GLOBE NEWSWIRE) -- A hemodialysis is a form of treatment used to remove water and waste from the blood. During kidney failure, dialysis removes wastes such as...
July 25, 2022 07:00 ET | Source: FibroGen, Inc.

FibroGen to Report Second Quarter 2022 Financial Results

SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2022 financial results on Monday, August 8 after the market close. FibroGen will also...
July 11, 2022 07:00 ET | Source: Algernon Pharmaceuticals

Algernon Pharmaceuticals Provides Update on its Planned Phase 1 Repirinast Chronic Kidney Disease Study

VANCOUVER, British Columbia, July 11, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a clinical stage Canadian...
May 27, 2022 06:01 ET | Source: The Insight Partners

Fluorescent Immunoassay Market Size, $3.77Bn by 2028, 5.6% CAGR Led by ELISA Segment (56.12% Market Share in 2021): The Insight Partners

NEw York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Fluorescent Immunoassay Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product...
May 27, 2022 02:47 ET | Source: The Insight Partners

$130.37Bn Hemodialysis and Peritoneal Dialysis Market 6.4% CAGR to 2028 Led by Hemodialysis (86.09% Revenue Share in 2022): The Insight Partners

New York, May 27, 2022 (GLOBE NEWSWIRE) -- The Insight Partners published latest research study on “Hemodialysis and Peritoneal Dialysis Market Forecast to 2028 - COVID-19 Impact and Global Analysis...
February 23, 2022 07:00 ET | Source: Algernon Pharmaceuticals

Algernon Pharmaceuticals Begins Manufacturing of Repirinast and Launches New Chronic Kidney Disease Research Program

VANCOUVER, British Columbia, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGWO) (OTCQB: AGNPF) a clinical stage pharmaceutical...
February 14, 2022 07:00 ET | Source: FibroGen, Inc.

FibroGen to Report Fourth Quarter and Full Year 2021 Financial Results

SAN FRANCISCO, Feb. 14, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its fourth quarter and full year 2021 financial results on Monday, February 28 after the market close....
February 09, 2022 17:15 ET | Source: The Rosen Law Firm PA

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Reata Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RETA

NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) between...
February 04, 2022 07:00 ET | Source: FibroGen, Inc.

FibroGen to Present at SVB Leerink 11th Annual Global Healthcare Conference

SAN FRANCISCO, Feb. 04, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced that Enrique Conterno, Chief Executive Officer, will participate in a fireside chat at the SVB Leerink...
January 25, 2022 08:00 ET | Source: Kismetly, Inc.

KidneyDiet App Brings Expert Nutritional Guidance to Those Suffering from Chronic Kidney Disease

BOULDER, Colo., Jan. 25, 2022 (GLOBE NEWSWIRE) -- Kismetly Inc., maker of the number one downloaded kidney-health nutrition app to help people manage chronic kidney disease through informed...